Physician profile
Irina Dimitrova
NPI 1003847237
$4,068.23
in general payments reported to CMS, 2019-2025
12 companies · $587 in 2025
The $587 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $245 · 2020: $226 · 2023: $1,156 · 2024: $1,854 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,838 · Food and Beverage: $1,384 · Education: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,838.49 |
| Food and Beverage | $1,383.78 |
| Education | $375.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Asensus Surgical, INC. | $1,156.39 | 2023 | Senhance |
| Intuitive Surgical, INC. | $1,133.87 | 2024 | |
| Merck Sharp & Dohme LLC | $636.64 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Abbvie INC. | $279.06 | 2024-2025 | |
| Glaxosmithkline, LLC. | $250.00 | 2024-2025 | Jemperli |
| Karyopharm Therapeutics INC. | $218.26 | 2024-2025 | Xpovio |
| Eisai INC. | $138.68 | 2024-2025 | |
| Astrazeneca Pharmaceuticals Lp | $115.26 | 2020 | |
| Baxter Healthcare | $78.24 | 2024 | Perclot |
| Caris Mpi, INC. | $27.47 | 2025 | Mi Cancer Seek |
| Exact Sciences Corporation | $24.16 | 2025 | Cologuard Collection Kit |
| Clovis Oncology, INC. | $10.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irina Dimitrova listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.